Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage

In patients with AF with previous ICH, restarting OAC therapy is associated with increased risks of recurrent ICH and major bleeding, without a corresponding reduction in thromboembolic events or all-cause mortality.